SYNOPSIS In this study the method of Ellis and Stransky (1961) to determine plasma fibrinogen is evaluated, and modifications are described which have been introduced to improve the sensitivity and reduce the time taken for the test.
Hypofibrinogenaemia has become increasingly recognized as a major factor in the bleeding disorders of pregnancy during the past decade. Most of the methods for the measurement of fibrinogen are lengthy and require considerable technical skill and experience to obtain reliable results. Schneider (1951) introduced the thrombin titre method which has the advantageofsimplicity, and a modification of this is now generally used in emergencies. Ellis and Stransky (1961) , using a thrombin reagent to polymerize fibrinogen, measured the turbidity produced spectrophotometrically and expressed the results as fibrinogen concentration. Bottema and Vervoort (1964) later extended the technique to demonstrate fibrinolysis.
Experience with these two methods has shown that accurate fibrinogen determinations are difficult at low levels due to low sensitivity and that the time taken for the test may lead to a delay in treatment.
Materials and Methods

SAMPLE
Venous blood is anticoagulated with one tenth Received for publication 20 March 1969. its volume of 3 -8 % sodium citrate. The plasma is separated by centrifugation at 3,000 rpm for three minutes.
REAGENTS
1 Barbitone-saline buffer, 0X1 M, pH 7-2: 2-93 g sodium chloride and 5-71 g sodium di-ethyl barbiturate are dissolved in about 900 ml deionized water. The solution is titrated with 1 0 N hydrochloric acid to pH 7-2 using a pH meter. About 22-5 ml is required. Make the volume to 1 litre with water.
2 Calcium chloride, 3-38 M 3 Sodium chloride, 0 9 % 4 Thrombin (Parke-Davis) is reconstituted in saline to a concentration of 1,000 NIH units per ml.
5 Calcium-thrombin reagent, for which 0-1 ml reconstituted thrombin is diluted with 1-9 ml 0 9 % sodium chloride and 2-0 ml 3 38 M calcium chloride, is added. After mixing this reagent is storedat4°Cwhen not in use and has a useable life of at least 24 hours.
TECHNIQUE
The recording spectrophotometer (Unicam SP800A) is programmed to read changes in absorbance against time at a fixed wavelength of 300 nm.
Plasma, 0 5 ml, is diluted with 5 5ml barbitone- The factor 10 is to correct for anticoagulant 9 dilution.
Experimental and Results
WAVELENGTH
Initial experiments with the Ellis-Stransky technique confirmed that at 470 nm, the wavelength used by these workers, sensitivity was inadequate for the measurement of low levels of fibrinogen. A further experiment carried out at 660 nm, as used by Bottema and Vervoort (1964) , showed less sensitivity ( Fig. 1) . A fibrinogen determination was carried out according to our technique and after 20 minutes a complete spectral scan was recorded over the range 215-700 nm (Fig. 2) . There was no peak of absorbance but a general increase in absorbance with decrease in wavelength. Below 280 nm the trace became very 'noisy', and therefore 300 nm was selected as the working wavelength, since this provides maximum sensitivity. TIME Ellis and Stransky (1961) Wavelength (n.m.) Ratnoff and Menzie (1951) . In this modification protein was precipitated, collected and washed as in the original technique, and then dissolved in 4 ml 0-2 N sodium hydroxide by heating in a boiling water bath for 15 minutes. After cooling, 0-2 ml 4% copper sulphate was added and the tubes were shaken vigorously for about a minute. The colour was developed by incubating the tubes at 37°C for 20 minutes and the optical density at 560 nm was observed after centrifuging at 2,500 rpm for two minutes. A standard was prepared with each batch of analyses by diluting 0 1 ml standard protein solution with 3 9 ml 0-2 N sodium hydroxide, adding 4% copper sulphate, and developing the colour as in the tests. As a blank, 4 ml 0-2 N sodium hydroxide was treated with 4% copper sulphate and the colour developed.
Twenty-three plasma samples were analysed in duplicate by this procedure and the same samples were analysed, again in duplicate, by our method.
The results are shown in Table II (Sharp, Howie, Biggs, and Methuen, 1958) .
The use of a recording spectrophotometer for our technique is not essential, but a reliable ultraviolet spectrophotometer is necessary to produce the sensitivity although the calibration data would need to be verified for each instrument before routine use. One advantage of using a recording instrument is that it can detect fibrinolysis, since the curve shows a demonstrable fall after reaching a maximum absorbance value in some cases where plasmin is present in high concentrations. A similar fall can be obtained in vitro by adding streptokiinase to the reaction mixture as described previously by Bottema and Vervoort (1964) and this can be neutralized by the addition of one of the fibrinolytic inhibitors.
We have used this modification of the method of Ellis and Stransky in obstetrical practice in the routine assessment of patients with antepartum haemorrhage, intrauterine death, and with bleeding after delivery. The main practical advantage is that an accurate and reliable result can be rapidly obtained by a relatively simple procedure and therefore an initial assessment of the condition and adequate monitoring of the response to therapy is readily available.
